These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38554345)

  • 21. HER2 gene (ERBB2) amplification is a low-frequency driver with potential predictive value in gallbladder carcinoma.
    Albrecht T; Rausch M; Roessler S; Geissler V; Albrecht M; Halske C; Seifert C; Renner M; Singer S; Mehrabi A; Vogel MN; Pathil-Warth A; Busch E; Köhler B; Rupp C; Weiss KH; Springfeld C; Röcken C; Schirmacher P; Goeppert B
    Virchows Arch; 2020 Jun; 476(6):871-880. PubMed ID: 31838585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A significant subgroup of resectable gallbladder cancer patients has an HER2 positive status.
    Yoshida H; Shimada K; Kosuge T; Hiraoka N
    Virchows Arch; 2016 Apr; 468(4):431-9. PubMed ID: 26758058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human epidermal growth factor receptor 2 neu expression in head and neck squamous cell cancers and its clinicopathological correlation: Results from an Indian cancer center.
    Vats S; Ganesh MS; Agarwal A
    Indian J Pathol Microbiol; 2018; 61(3):313-318. PubMed ID: 30004046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relationship between HER2/neu gene amplification and protein expression and prognosis in patients with advanced gastric carcinoma].
    Song Y; Huang J; Wang JW
    Chin J Cancer; 2010 Jan; 29(1):76-81. PubMed ID: 20038314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis.
    Haderlein M; Scherl C; Semrau S; Lettmaier S; Hecht M; Erber R; Iro H; Fietkau R; Agaimy A
    Strahlenther Onkol; 2017 Nov; 193(11):961-970. PubMed ID: 28828496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormonal Receptor, Human Epidermal Growth Factor and Its Association with Breast Cancer Tumor Characteristics in Albania.
    Pajenga E; Rexha T; Çeliku S; Ugrinska A; Bejtja G
    Cent Eur J Public Health; 2016 Sep; 24(3):171-175. PubMed ID: 27760283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical significance and underlying correlation of pStat-3 and integrin αvβ6 expression in gallbladder cancer.
    Enyu L; Na W; Chuanzong Z; Ben W; Xiaojuan W; Yan W; Zequn L; Jianguo H; Jiayong W; Benjia L; Cheng P; Min Z; Zongli Z
    Oncotarget; 2017 Mar; 8(12):19467-19477. PubMed ID: 28061445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of neoadjuvant chemotherapy on HER2/neu status in invasive breast cancer.
    Li P; Liu T; Wang Y; Shao S; Zhang W; Lv Y; Yi J; Wang Z
    Clin Breast Cancer; 2013 Feb; 13(1):53-60. PubMed ID: 23103368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic and prognostic significance of overexpression of her-2/neu and p53 oncoproteins in gastric carcinoma using tissue microarray.
    Ismail HM; Moneer M; El-Baradie M; Khorshid O; Touny A
    J Egypt Natl Canc Inst; 2007 Jun; 19(2):147-57. PubMed ID: 19034345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder Cancer.
    Hryciuk B; Pęksa R; Bieńkowski M; Szymanowski B; Radecka B; Winnik K; Żok J; Cichowska N; Iliszko M; Duchnowska R
    Sci Rep; 2020 Feb; 10(1):1871. PubMed ID: 32024900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients with HER2-positive early breast cancer receiving adjuvant trastuzumab: clinicopathological features, efficacy, and factors affecting survival.
    Ulas A; Kos T; Avci N; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
    Asian Pac J Cancer Prev; 2015; 16(4):1643-9. PubMed ID: 25743846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of HER2/neu expression in gastric cancer.
    Ananiev J; Gulubova M; Manolova I; Tchernev G
    Wien Klin Wochenschr; 2011 Jul; 123(13-14):450-4. PubMed ID: 21739203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological prognostic factors for gallbladder carcinoma: a retrospective study.
    Ramalhosa F; Amaral MJ; Serôdio M; Oliveira RC; Teixeira P; Cipriano MA; Tralhão JG
    J Gastrointest Oncol; 2022 Aug; 13(4):1997-2006. PubMed ID: 36092357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of TROP2 expression in patients with gallbladder cancer.
    Chen MB; Wu HF; Zhan Y; Fu XL; Wang AK; Wang LS; Lei HM
    Tumour Biol; 2014 Nov; 35(11):11565-9. PubMed ID: 25135430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of HER2 status in bladder transitional cell carcinoma revealed by both IHC and BDISH techniques.
    Nedjadi T; Al-Maghrabi J; Assidi M; Dallol A; Al-Kattabi H; Chaudhary A; Al-Sayyad A; Al-Ammari A; Abuzenadah A; Buhmeida A; Al-Qahtani M
    BMC Cancer; 2016 Aug; 16():653. PubMed ID: 27539085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Value of KIF2A and HER2-Neu Overexpression in Patients With Epithelial Ovarian Cancer.
    Wang D; Zhu H; Ye Q; Wang C; Xu Y
    Medicine (Baltimore); 2016 Feb; 95(8):e2803. PubMed ID: 26937910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan.
    Li JW; Chuang TC; Yang AH; Hsu CK; Kao MC
    Int J Oncol; 2005 Apr; 26(4):933-43. PubMed ID: 15753987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HER2 Positivity Is Affected by the Papillary Structure and Has a Bidirectional Prognostic Value for Gallbladder Carcinoma.
    Chen L; Xu L; Shen L; Luo R; Jiang D; Wang Y; Li W; Hou Y
    Front Genet; 2021; 12():831318. PubMed ID: 35265100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue microarray-based study of patients with lymph node-negative breast cancer shows that HER2/neu overexpression is an important predictive marker of poor prognosis.
    Choi YH; Ahn JH; Kim SB; Jung KH; Gong GY; Kim MJ; Son BH; Ahn SH; Kim WK
    Ann Oncol; 2009 Aug; 20(8):1337-43. PubMed ID: 19221151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of prognostic different subgroups in triple negative breast cancer by Her2-neu protein expression.
    Schmidt G; Meyberg-Solomayer G; Gerlinger C; Juhasz-Böss I; Herr D; Rody A; Liedtke C; Solomayer EF
    Arch Gynecol Obstet; 2014 Dec; 290(6):1221-9. PubMed ID: 25012601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.